Abstract
Method comparisons are routinely performed in hospital laboratories as part of the regulatory approval process. These trials are often biased in several ways. There is often a conflict of interest bias because the hospital is paid for the trial by the manufacturer of the assay. Moreover, the trial itself is often conducted in a way that is different from routine use. The reagents selected for the trial cannot be randomly selected from all possible reagents since future reagents do not exist. Yet, future reagents often have new lots of raw materials and/or changed manufacturing procedures, which can affect assay trueness. User error is often minimized because the user chosen to perform the study receives more training then would be routinely provided. All of these factors can lead to better performance in the regulatory evaluation then performance seen after release for sale as shown by examples for glucose meters. The above biases are largely unavoidable. Steps are suggested to reduce the above biases.
Similar content being viewed by others
References
ISO 15197:2003 (2003) In vitro diagnostic test systems—requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus. International Organization for Standardization, Geneva
Brazg RL, Klaff LJ, Parkin CG (2013) Performance variability of seven commonly used self-monitoring of blood glucose systems: clinical considerations for patients and providers. J Diabetes Sci Technol 7:144–152
Freckmann G, Baumstark A, Jendrike N et al (2010) System accuracy evaluation of 27 blood glucose monitoring systems according to DIN EN ISO 15197. Diabetes Technol Ther 12:221–231
Klonoff DC, Lias C, Vigersky R et al (2014) The surveillance error grid. J Diabetes Sci Technol 8:658–672
Author information
Authors and Affiliations
Corresponding author
Additional information
Papers published in this section do not necessarily reflect the opinion of the Editors, the Editorial Board, and the Publisher.
A critical and constructive debate in the Discussion Forum or a Letter to the Editor is strongly encouraged!
Rights and permissions
About this article
Cite this article
Krouwer, J.S. Biases in clinical trials performed for regulatory approval. Accred Qual Assur 20, 437–439 (2015). https://doi.org/10.1007/s00769-015-1145-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00769-015-1145-0